Paper Details

  1. Home
  2. Paper Details

Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group.

Author: CamrasC B, CioffiG A, HigginbothamE J, KatzL J, KaufmanP L, KrupinT, LustgartenJ, MincklerD, RitchR, RobinA L, SchumerR A, SherwoodM, StewartW C, StjernschantzJ, WaxM B, WeinrebR, WilenskyJ, ZimmermanT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Latanoprost was more effective than timolol in reducing intraocular pressure in glaucoma patients. Switching from timolol to latanoprost resulted in a significant decrease in intraocular pressure, and the drug was well-tolerated, with only a slight increase in conjunctival hyperemia.
Paper Details　
Original Abstract of the Article :
PURPOSE: To determine the efficacy and safety of latanoprost treatment for 1 year in glaucoma patients, and to evaluate the effects of switching from timolol to latanoprost therapy. METHODS: Latanoprost 0.005% was topically applied once daily without masking for 6 months in 223 patients with elevat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0002-9394(98)00094-4

データ提供：米国国立医学図書館（NLM）

Latanoprost: A Promising Treatment for Glaucoma

The search for effective and safe treatments for glaucoma, a condition that can lead to irreversible blindness, is an ongoing endeavor. This study examines the efficacy and safety of latanoprost, a prostaglandin analogue, in managing intraocular pressure (IOP), a key factor in the progression of glaucoma.

The study, conducted over a year, demonstrated that latanoprost effectively reduced IOP in patients with glaucoma, with a significant reduction in IOP observed over the duration of the study. Moreover, switching from timolol, another commonly used antiglaucoma medication, to latanoprost resulted in a further reduction in IOP, suggesting that latanoprost might offer a more effective alternative.

Latanoprost: A Potential Breakthrough in Glaucoma Treatment

The study's findings suggest that latanoprost holds promise as a safe and effective treatment for glaucoma, potentially offering a significant improvement in IOP control. The potential for reduced IOP could slow the progression of glaucoma and potentially preserve vision in affected individuals.

Glaucoma: New Hope on the Horizon

This research shines a light on the potential of latanoprost as a valuable tool for glaucoma management. It offers hope for patients struggling with this debilitating condition, potentially slowing its progression and preserving their vision. Think of it, my dear readers, like a cool oasis in the scorching desert, providing much-needed relief from the harsh conditions.

Dr.Camel's Conclusion

This research highlights the potential of latanoprost as a promising treatment for glaucoma. It could provide a more effective alternative to existing treatments, potentially leading to better outcomes for patients. The journey through the vast desert of ophthalmology continues, and latanoprost could be a valuable guide for navigating the challenges of glaucoma.

Date :
  1. Date Completed 1998-09-23
  2. Date Revised 2019-06-27
Further Info :

Pubmed ID

9744372

DOI: Digital Object Identifier

10.1016/s0002-9394(98)00094-4

Related Literature

Article Analysis
・Effects of timolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.